Filter
432
Text search:
HIV
coinfection
Featured
Recommendations
46
New Publications
121
Language
Document type
No document type
307
Studies & Reports
44
Guidelines
43
Situation Updates
11
Fact sheets
7
Strategic & Response Plan
6
Manuals
5
Training Material
5
Infographics
2
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
Western and Central Europe
18
Eastern Europe
17
Nepal
16
India
15
Latin America and the Carribbean
14
Asia
10
Rwanda
8
Namibia
8
South–East Asia Region
8
Global
8
Kenya
7
Tanzania
7
Ukraine
7
Myanmar / Burma
7
Congo, Democratic Republic of
6
Malawi
6
Russia
6
Nigeria
5
Ethiopia
5
Philippines
5
Zambia
5
Cambodia
5
South Africa
5
Sierra Leone
4
Ghana
4
Bangladesh
4
Argentina
3
Africa
3
Liberia
2
Senegal
2
Uganda
2
Zimbabwe
2
Mozambique
2
Benin
2
Peru
2
Brazil
2
Madagascar
2
Eastern Europe and Central Asia
2
Albania
2
Armenia
2
Tajikistan
2
Georgia
2
Haiti
1
Pakistan
1
Germany
1
Thailand
1
Indonesia
1
Central African Republic
1
Eswatini/ Swaziland
1
Colombia
1
Ecuador
1
East and Southern Africa
1
Paraguay
1
Laos
1
Estonia
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
North America
1
Azerbaijan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
154
Clinical Guidelines
60
Public Health
6
Pharmacy & Technologies
5
Women & Child Health
4
Key Resources
4
Capacity Building
3
Toolboxes
TB
129
HIV
124
NTDs
17
Refugee
8
COVID-19
7
AMR
3
Caregiver
3
Ebola
2
Rapid Response
2
Mental Health
2
Global Health Education
2
Pharmacy
2
Polio
1
Conflict
1
Zika
1
Planetary Health
1
Health Financing Toolbox
1
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen
...
Technical and operational ‘how-to’: practical considerations
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
Настоящие руководящие принципы предназначены для специалистов, имеющих дело с теми потребителями наркотиков, которые применяют наиболее проблемные модели потре
...
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2015, Article ID 752709, 7 pages
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...